Search results for " Atri"

showing 10 items of 304 documents

Role of Rate Control and Regularization Through Pacing in Patients With Chronic Atrial Fibrillation and Preserved Ventricular Function: The VRR Study

2006

Aim: High heart rates in chronic atrial fibrillation (CAF) is one of the factors responsible for hemodynamic alterations and may lead to tachycardiomyopathies. The ventricular rate regulation (VRR) study evaluates the effect of ventricular rate regularization in CAF patients with preserved ventricular function, marked ventricular rate variability, and indications for pacemaker (PM) implantation owing to symptomatic pauses. Rate regularization was achieved using VRR algorithm (INSIGNIA® pacemakers, Guidant Corp., St. Paul, MN, USA). Methods: One month after PM implantation, 58 patients followed two 3-month crossover periods (VRR-OFF; VRR-ON) in which the VRR algorithm was randomized and comp…

Malemedicine.medical_specialtyHemodynamicsVentricular Dysfunction LeftHeart RateInternal medicineAtrial FibrillationmedicineHumansChronic atrial fibrillationIn patientLead (electronics)Ventricular functionbusiness.industryCardiac Pacing ArtificialRate controlAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseTreatment OutcomeWalk testAnesthesiaChronic DiseaseTachycardia VentricularCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPacing and Clinical Electrophysiology
researchProduct

Clinical predictors to identify paroxysmal atrial fibrillation after ischaemic stroke.

2013

Background and purpose Detection of paroxysmal atrial fibrillation (pAF) after an ischaemic cerebrovascular event is of imminent interest, because oral anticoagulation as a highly effective secondary preventive treatment is available. Whereas permanent atrial fibrillation (AF) can be detected during routine electrocardiogram (ECG), longer detection duration will detect more pAF but might be resource consuming. The current study tried to identify clinical predictors for pAF detected during long-term Holter ECG and clinical follow-up. Methods Patients with acute ischaemic stroke were prospectively investigated with an intensified algorithm to detect pAF (7-day Holter ECG, follow-up investigat…

Malemedicine.medical_specialtyMultivariate analysisParoxysmal atrial fibrillation030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciencesElectrocardiography0302 clinical medicineInternal medicineIschaemic strokeAtrial FibrillationmedicineHumanscardiovascular diseasesAgedbusiness.industryAtrial fibrillationOdds ratiomedicine.diseaseConfidence interval3. Good healthClinical trialStrokeNeurologyCardiologyElectrocardiography AmbulatoryFemaleNeurology (clinical)business030217 neurology & neurosurgeryAlgorithmsEuropean journal of neurology
researchProduct

Paroxysmal atrial fibrillation and high degree AV block: use of single-lead VDDR pacing with mode switching.

1998

Dual chamber rate responsive pacing incorporating a mode switching option is increasingly used in patients with chronic paroxysmal atrial fibrillation and high degree AV block. Single-lead VDDR pacemakers have rarely used for this indication. The purpose of this study was to determine their reliability of atrial sensing during atrial fibrillation, the percentage of atrial synchronous ventricular pacing, and the behavior of the sinus rate outside the phases of atrial fibrillation. We studied ten patients with a single-lead VDDR pacemaker implanted for this indication. Follow-up visits were performed at predischarge and after 1, 3, 6, 12, 18, and 24 months. During the mean follow-up period of…

Malemedicine.medical_specialtyPacemaker ArtificialTime FactorsParoxysmal atrial fibrillationVentricular stimulationInternal medicineAtrial FibrillationMedicineHumansSinus rhythmIn patientcardiovascular diseasesbusiness.industryP waveCardiac Pacing ArtificialAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseHeart BlockSingle leadAnesthesiacardiovascular systemCardiologyMode switchingFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesPacing and clinical electrophysiology : PACE
researchProduct

Automatic detection of paroxysmal atrial fibrillation in patients with ischaemic stroke: better than routine diagnostic workup?

2016

Background and purpose Prolonged electrocardiogram (ECG) monitoring after ischaemic stroke increases the diagnostic yield of paroxysmal atrial fibrillation (pAF). In order to facilitate the additional workload involved in ECG analysis due to prolonged monitoring times, we investigated the effectiveness of pAF detection with an automated software algorithm (SA) in comparison to the routine staff-based analysis (RA) during standard stroke-unit care. Therefore, patients with acute ischaemic stroke or transitory ischaemic attack presenting with sinus rhythmus on the admission ECG and no history of atrial fibrillation were prospectively included. Methods A 24-h Holter ECG assessment was performe…

Malemedicine.medical_specialtyParoxysmal atrial fibrillation030204 cardiovascular system & hematologyBrain Ischemiatransitory ischaemic attackCohort StudiesAutomation03 medical and health sciences0302 clinical medicineInternal medicineAtrial FibrillationIschaemic strokemedicineHumansIn patientProspective Studiescardiovascular diseasesStrokeAgedAged 80 and overstroke unitbusiness.industryCerebral infarctionAtrial fibrillationOriginal ArticlesMiddle Agedcerebral infarctionmedicine.diseasestrokeHolter electrocardiogramConfidence interval3. Good healthHospitalizationNeurologyIschemic Attack TransientCohortElectrocardiography AmbulatoryCardiologyFemaleOriginal ArticleNeurology (clinical)businessAlgorithms030217 neurology & neurosurgeryEuropean Journal of Neurology
researchProduct

Depolarization-induced influx of sodium in response to phenylephrine in rat atrial heart muscle.

1991

1. The effects of alpha 1-adrenoceptor stimulation on transmembrane potential, currents and ion fluxes were investigated in multicellular preparations and/or single cells obtained from the left atrium of rat hearts. 2. In multicellular preparations, phenylephrine caused a concentration-dependent positive inotropic effect, an increase in action potential duration, and a decrease in resting potential; the effects were antagonized by phentolamine. 3. In the presence of phenylephrine (100 mumol/1), two levels of resting potential were observed when the preparations were, alternately, electrically stimulated or kept at rest (-74 +/- 1 mV during activity and -62 +/- 4 mV at rest; mean +/- S.E.M.;…

Malemedicine.medical_specialtyPhysiologyVoltage clampAction PotentialsStimulationMembrane PotentialsPhenylephrinechemistry.chemical_compoundPhentolamineInternal medicinemedicineAnimalsHeart AtriaPhenylephrineMembrane potentialChemistryMyocardiumSodiumRats Inbred StrainsDepolarizationMyocardial ContractionResting potentialStimulation ChemicalRatsElectrophysiologyEndocrinologyTetrodotoxinCalciumResearch Articlemedicine.drugThe Journal of Physiology
researchProduct

Permanent left atrial pacing therapy may improve symptoms in heart failure patients with preserved ejection fraction and atrial dyssynchrony: a pilot…

2012

Aims Our group has recently shown that in some patients, heart failure with preserved ejection fraction (HFPEF) may be explained by ‘atrial dyssynchrony syndrome’ (ADS) due to interatrial conduction delay (IACD), a short left atrioventricular interval (LAVI), and increased left atrial (LA) stiffness. Our primary objective was to evaluate LA pacing therapy as a new treatment to restore left ventricular active filling in patients with no other known causes for HF than ADS. Methods and results Six patients with severe HFPEF with IACD (P wave duration >120 ms in lead II), short LAVI during electrophysiological studies ( 15), and no standard indication for a pacemaker were implanted with a lead …

Malemedicine.medical_specialtyPilot ProjectsSeverity of Illness IndexHeart RateInternal medicineAtrial FibrillationHeart ratemedicineHumansHeart AtriaCoronary sinusAgedHeart FailureCross-Over StudiesEjection fractionbusiness.industryCardiac Pacing ArtificialStroke VolumeAtrial fibrillationStroke volumemedicine.diseaseCrossover studyTreatment OutcomeHeart failureCardiologyFemaleFranceCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionEuropean Journal of Heart Failure
researchProduct

Helicobacter pylori and atrial fibrillation: absence of correlations

2009

Malemedicine.medical_specialtyRisk AssessmentGastroenterologyHelicobacter InfectionsRisk FactorsInternal medicineAtrial FibrillationmedicineHumansProspective StudiesProspective cohort studyHelicobacter pyloribiologybusiness.industryCase-control studyAtrial fibrillationGeneral MedicineMiddle AgedHelicobacter pylorimedicine.diseaseHelicobacter Infectionsbiology.organism_classificationInflammatory mediatorHelicobacter pylori atrial fibrillationCase-Control StudiesFemaleInflammation MediatorsCardiology and Cardiovascular MedicineRisk assessmentbusinessBiomarkersJournal of Cardiovascular Medicine
researchProduct

Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards

2010

Abstract Introduction Current guidelines for ischemic stroke prevention in atrial fibrillation or flutter (AFF) recommend Vitamin K antagonists (VKAs) for patients at high-intermediate risk and aspirin for those at intermediate-low risk. The cost-effectiveness of these treatments was demonstrated also in elderly patients. However, there are several reports that emphasize the underuse of pharmacological prophylaxis of cardio-embolism in patients with AFF in different health care settings. Aims To evaluate the adherence to current guidelines on cardio-embolic prophylaxis in elderly (> 65 years old) patients admitted with an established diagnosis of AFF to the Italian internal medicine wards p…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaVitamin Kantithrombotic therapyNOAntithrombotic prophylaxis Atrial fibrillation Platelet agents Vitamin K antagonistsFibrinolytic AgentsRisk FactorsInternal medicineAntithromboticInternal MedicinemedicineHumansatrial fibrillationRegistriesMedical prescriptionStrokeAgedRetrospective StudiesAged 80 and overAntithrombotic prophylaxis; Atrial fibrillation; Platelet agents; Vitamin K antagonists;guidelines; antithrombotic therapy; atrial fibrillation.AspirinAspirinbusiness.industryantithrombotic prophylaxis; atrial fibrillation; platelet agents; vitamin k antagonistsAtrial fibrillationRetrospective cohort studyplatelet agentsmedicine.diseaseStrokevitamin k antagonistsIntracranial EmbolismItalyPlatelet aggregation inhibitorFemaleGuideline Adherenceantithrombotic prophylaxisbusinessguidelinePlatelet Aggregation InhibitorsFibrinolytic agentatrial fibrillation.medicine.drug
researchProduct

The effect of methacholine on noradrenaline release from the rabbit heart perfused with indometacin

1974

The experiments were undertaken in order to study the effect of inhibition of prostaglandin synthesis on the muscarinic inhibition of noradrenaline release evoked by sympathetic nerve stimulation. The right sympathetic nerves of the perfused rabbit heart were stimulated electrically. The noradrenaline output was enhanced after perfusion of the hearts with indometacin 3×10−5 M indicating blockade of the prostaglandin-mediated negative feedback control. Both in the presence and in the absence of indometacin methacholine 4×10−5 M decreased the noradrenaline output by a similar percentage. It is concluded that the muscarinic inhibition of noradrenaline release does not require the functional in…

Malemedicine.medical_specialtySympathetic Nervous SystemTime FactorsHeart VentriclesIndomethacinSympathetic nerveStimulationIn Vitro TechniquesFeedbackNorepinephrineIndometacinHeart RateInternal medicineMuscarinic acetylcholine receptormedicineAnimalsMethacholine CompoundsHeart AtriaPharmacologyChemistryMyocardiumRabbit heartHeartGeneral MedicineElectric StimulationStimulation ChemicalBlockadePerfusionEndocrinologyDepression ChemicalProstaglandinsFemaleMethacholineRabbitsPerfusionmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treate…

2021

Background We assessed the impact of preprocedural plasma levels of MRproANP (midregional N‐terminal pro–atrial natriuretic peptide) and sST2 (soluble suppression of tumorigenicity 2) on recurrence of atrial fibrillation (AF) at 1 year after catheter ablation of AF. Methods and Results This was a prospective, multicenter, observational study including patients undergoing catheter ablation of AF. MRproANP and sST2 were measured in a peripheral venous blood preprocedure, and MRproANP was assessed in the right and left atrial blood during ablation. The primary end point was recurrent AF between 3 and 12 months postablation, defined as a documented (>30 seconds) episode of AF, flutter, or a…

Malemedicine.medical_specialtyTime Factorsmedicine.drug_classmedicine.medical_treatmentBiorhythmCatheter ablation030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineHeart RatePredictive Value of TestsRecurrenceRisk FactorsInternal medicinecatheter ablationAtrial FibrillationmedicineNatriuretic peptideHumansIn patientArrhythmia and Electrophysiology030212 general & internal medicineHeart AtriaProspective StudiesOriginal ResearchAgedsST2business.industryMRproANPbiomarkersAtrial fibrillationPlasma levelsMiddle Agedmedicine.diseaseInterleukin-1 Receptor-Like 1 ProteinUp-RegulationHeart RhythmTreatment OutcomePro atrial natriuretic peptideCardiologyFemaleFranceCardiology and Cardiovascular MedicinebusinessCatheter Ablation and Implantable Cardioverter-DefibrillatorAtrial Natriuretic FactorJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
researchProduct